Determination of the covalent adducts of the novel anti-cancer agent 5,6-dimethylxanthenone-4-acetic acid in biological samples by high-performance liquid chromatography

Journal of Chromatography B: Biomedical Sciences and Applications

Volumn 757, Issue 2, 2001, Pages 343-348

  Zhou, Shufeng ^a   Paxton, James W ^a   Tingle, Malcolm D ^a   Kestell, Phillip ^b  

^a THE UNIVERSITY OF AUCKLAND   (New Zealand)

^b UNIVERSITY OF AUCKLAND   (New Zealand)

Author keywords

5,6 Dimethylxanthenone 4 acetic acid

Indexed keywords

ACETIC ACID; ACETONITRILE; FLUORESCENCE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HYDROLYSIS; PROTEINS; TUMORS;

ANTI-CANCER AGENTS;

CHROMATOGRAPHIC ANALYSIS;

5,6 DIMETHYLXANTHENONE 4 ACETIC ACID; ACETONITRILE; AMMONIUM ACETATE; ANTINEOPLASTIC AGENT; BUFFER; GLUCURONIDE; HUMAN SERUM ALBUMIN;

ACCURACY; ANALYTIC METHOD; ARTICLE; CALCULATION; CALIBRATION; CONCENTRATION (PARAMETERS); COVALENT BOND; DRUG HYDROLYSIS; FLOW RATE; FLUORESCENCE; HUMAN; HUMAN TISSUE; PRIORITY JOURNAL; QUALITY CONTROL; REVERSED PHASE HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; VALIDATION PROCESS;

ANTINEOPLASTIC AGENTS; CALIBRATION; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY; SERUM ALBUMIN; XANTHENES; XANTHONES;

EID: 0035877314     PISSN: 13872273     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0378-4347(01)00173-6     Document Type: Article

References (23)

1. Philpott M., Baguley B.C., Ching L.-M. Chemother. Pharmacol. 36:1995;143.
2. Philpott M., Joseph W.R., Crosier K.E., Baguley B.C., Ching L.-M. Br. J. Cancer. 76:1997;1586.
3. Joseph W.R., Cao Z., Mountjoy K.G., Marshall E.S., Baguley B.C., Ching L.M. Cancer. Res. 59:1999;633.
4. Thomsen L.L., Ching L.-M., Baguley B.C. Cancer Res. 50:1990;6966.
5. Thomsen L.L., Ching L.-M., Zhuang L., Gavin J.B., Baguley B.C. Cancer Res. 51:1991;77.
6. Baguley B.C., Zhuang L., Kestell P. Oncol. Res. 9:1997;55.
7. Webster L.K., Ellis A.G., Kestell P., Rewcastle G.W. Drug. Metab. Dispos. 23:1995;363.
8. Miners J.O., Valente L., Lillywhite K.J., Mackenzie P.I., Burchell B., Baguley B.C., Kestell P. Cancer. Res. 57:1997;284.
9. Kestell P., Paxton J.W., Rewcastle G.W., Dunlop I., Baguley B.C. Cancer Chemother. Pharmacol. 43:1999;323.
10. Faed E.M. Drug Metab. Rev. 15:1984;1213.
11. Spahn-lugguth H., Benet L.Z. Drug Metab. Rev. 24:1992;5.
12. Hermening A., Grafe A.K., Baktir G., Mutschler E., Spahn-Lugguth H. J. Chromatogr. B. 741:2000;129.
13. Smith P.C., Benet L.Z., Mcdonagh A.F. Drug Metab. Dispos. 18:1990;639.
14. Bischer A., Ziaamirhosseini P., Iwaki M., Mcdonagh A.F., Benet L.Z. J. Pharmacokinet. Biopharm. 23:1995;379.
15. Rewcastle G.W., Atwell G.I., Baguley B.C., Calveley S.B., Denny W.A. J. Med. Chem. 32:1989;793.
16. Rewcastle G.W., Kestell P., Baguley B.C., Denny W.A. J. Natl. Cancer Inst. 82:1990;528.
17. Smith P.C., Benet L.Z., Mcdonagh A.F. J. Clin. Invest. 77:1986;934.
18. Sallustio B.C., Foster D.J.R. Drug Metab. Dispos. 23:1995;892.
19. Sallustio B.C., Fairchild B.A., Pannall P.R. Drug Metab. Dispos. 25:1997;55.
20. Smith P.K., Krohn R.I., Hermanson G.T., Mallia A.K., Garter F.H., Provenzano M.D., Fujimoto E.K., Goeke N.M., Olson B.J., Klenk D.C. Ann. Biochem. 150:1985;76.
21. Pohl L.R., Satoh H., Christ D.D., Kenna J.G. Annu. Rev. Pharmacol. 28:1988;367.
22. Kames H.T., Shiu G., Shah V.P. Pharm. Res. 8:1991;421.
23. Shah V.P., Midha K.K., Dighe S., McGilveray I.J., Skelly J.P., Yacobi A. Pharm. Res. 9:1992;588.